NASDAQ: ALLKAllakos Inc Stock Ownership - Who owns Allakos?
Insider buying vs selling
Have Allakos Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Alexander | Chief Executive Officer | 2025-03-06 | 31,370 | $0.26 | $8.16kSell |
| Adam Tomasi | President | 2025-03-05 | 20,017 | $0.26 | $5.20kSell |
| Harlan Baird Radford | Chief Financial Officer | 2025-03-05 | 14,161 | $0.26 | $3.68kSell |
| Harlan Baird Radford | Chief Financial Officer | 2024-12-06 | 13,138 | $1.10 | $14.45kSell |
| Adam Tomasi | President | 2024-12-06 | 21,116 | $1.10 | $23.23kSell |
| Robert Alexander | Chief Executive Officer | 2024-12-05 | 32,466 | $1.10 | $35.71kSell |
| Chin Hyok Lee | Chief Medical Officer | 2024-12-04 | 10,634 | $1.13 | $12.02kSell |
| Robert Alexander | Chief Executive Officer | 2024-09-11 | 37,311 | $0.58 | $21.64kSell |
| Chin Hyok Lee | Chief Medical Officer | 2024-09-09 | 45,320 | $0.65 | $29.46kSell |
| Adam Tomasi | President | 2024-09-06 | 21,961 | $0.65 | $14.27kSell |
ALLK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALLK insiders and whales buy or sell their stock.
ALLK Shareholders
What type of owners hold Allakos Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Daniel Janney | 19.48% | 17,569,693 | $5.71M | Insider |
| Bvf Inc | 18.35% | 16,552,417 | $5.38M | Institution |
| John P. McKearn | 13.37% | 12,064,128 | $3.92M | Insider |
| Rivervest Venture Fund III LP | 13.37% | 12,064,128 | $3.92M | Insider |
| Alta Partners VIII LP | 12.77% | 11,519,200 | $3.74M | Insider |
| Paul Edward Walker | 9.33% | 8,413,935 | $2.73M | Insider |
| Alta Partners Nextgen Fund I Management LLC | 7.18% | 6,477,967 | $2.11M | Insider |
| Guy P. Nohra | 7.15% | 6,448,053 | $2.10M | Insider |
| Nea Management Company LLC | 6.81% | 6,147,260 | $2.00M | Institution |
| Deep Track Capital LP | 6.32% | 5,704,282 | $1.85M | Institution |
ALLK vs Biotech Stocks
Allakos Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.